PREDICTION OF THE TREATMENT RESPONSE TO AN ANTI-EGFR MOLECULE IN COLORECTAL CANCER PATIENTS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Dec 3, 2015
app pub date -
Dec 16, 2013
filing date -
Dec 20, 2012
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The present invention relates to a method for predicting the treatment response to an anti-epidermal growth factor receptor (EGFR) molecule in a patient suffering from colorectal cancer. Furthermore, the present invention relates to an anti-EGFR molecule for use in the treatment of a patient suffering from colorectal cancer.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully